Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Khalaf Kridin & A. Razzaque Ahmed. (2021) The evolving role of rituximab in the treatment of pemphigus vulgaris: a comprehensive state-of-the-art review. Expert Opinion on Biological Therapy 21:4, pages 443-454.
Read now
Read now
Ayman Grada, Zaidal Obagi & Tania Phillips. (2019) Management of chronic wounds in patients with pemphigus. Chronic Wound Care Management and Research 6, pages 89-98.
Read now
Read now
Khalaf Kridin. (2018) Emerging treatment options for the management of pemphigus vulgaris. Therapeutics and Clinical Risk Management 14, pages 757-778.
Read now
Read now
Shawn Shetty & A. Razzaque Ahmed. (2017) Rituximab in the treatment of pemphigus. Expert Opinion on Orphan Drugs 5:1, pages 99-109.
Read now
Read now
Articles from other publishers (31)
Hiram Larangeira de AlmeidaJr.Jr. & Renata Heck. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments
647
655
.
Yangai Liu & Fei Wang. (2022) Failure of double filtration plasmapheresis to treat severe pemphigus vulgaris: A case report. Journal of Clinical Apheresis.
Crossref
Crossref
Iyad Majid, Brandon R Martel, Melanie Martel & Leslie K Tamura. (2022) Ocular Involvement in Pemphigus Vulgaris Without Skin Lesions: A Case Report. Cureus.
Crossref
Crossref
Huijie Yuan, Meng Pan, Hongxiang Chen & Xuming Mao. (2022) Immunotherapy for Pemphigus: Present and Future. Frontiers in Medicine 9.
Crossref
Crossref
Josquin Pieper, Robert Pollmann, Rüdiger Eming, Brandon Greene, Maik Hahmann & Michael Hertl. (2022) Register‐Studie zu Krankheitsentwicklung und Therapieansprechen bei Pemphigus. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:4, pages 461-468.
Crossref
Crossref
Josquin Pieper, Robert Pollmann, Rüdiger Eming, Brandon Greene, Maik Hahmann & Michael Hertl. (2022) Disease progression and response to therapy in pemphigus based on a registry. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:4, pages 461-467.
Crossref
Crossref
Vesna Miličić. (2022) Why a topical corticosteroid plus antibiotic?. Galenika Medical Journal 1:2, pages 23-30.
Crossref
Crossref
Eka Devinta Novi Diana, Wibisono Nugraha, Alfina Rahma, Frieda, Anindya Oktafiani, Rieska Widyaswari & Muhammad Eko Irawanto. (2021) Profil Pemphigus Vulgaris di Instalasi Rawat Inap RSUD Dr. Moewardi Surakarta Periode Januari 2014-Desember 2019. MEDICINUS 34:3, pages 27-34.
Crossref
Crossref
Ali M. Malik, Sarah Tupchong, Simo Huang, Abhirup Are, Sylvia Hsu & Kiran Motaparthi. (2021) An Updated Review of Pemphigus Diseases. Medicina 57:10, pages 1080.
Crossref
Crossref
K Subadra, Sathasivasubramanian S & Aravind Warrier S. (2021) Oral Pemphigus Vulgaris. Cureus.
Crossref
Crossref
Paramasivam PreethiDr.Dr., R.R. Mahendra RajDr.Dr., Thalaimalai SaravananDrDr & K.R. ShakilaDrDr. (2021) STEROID SPARING DRUGS IN IMMUNE MEDIATED MUCOCUTANEOUS DISEASES-A REVIEW ON THERAPEUTIC REGIMEN. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 49-51.
Crossref
Crossref
Federico Bardazzi, Camilla Loi, Adriano Chessa Marco, Ambra Di Altobrando, Federica Filippi, Rossella Lacava, Filippo Viviani, Riccardo Balestri, Miriam Leuzzi & Lidia Sacchelli. (2021) Therapeutic approaches and targets for treatment of autoimmune bullous diseases. Dermatologic Therapy 34:5.
Crossref
Crossref
S. Assaf, L. Malki, T. Mayer, J. Mohamad, A. Peled, M. Pavlovsky, K. Malovitski, O. Sarig, D. Vodo & E. Sprecher. (2021) ST18 affects cell–cell adhesion in pemphigus vulgaris in a tumour necrosis factor‐α‐dependent fashion*. British Journal of Dermatology 184:6, pages 1153-1160.
Crossref
Crossref
Kriti Sareen, Fozia Sultana, Zabin Mirza, Kalpna Thakur, Ekta Parmar & Prachi Patekar. (2021) Management of Pemphigus Vulgaris Using Dexamethasone Cyclophosphamide Pulse Therapy: A Case Report. Journal of Research and Advancement in Dentistry 12:5, pages 275-277.
Crossref
Crossref
Stephen E. Wolverton & Elizabeth A. Rancour. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
133
155.e4
.
Po-Yuan Wu, Te-Mao Li, Shu-I. Chen, Chao-Jung Chen, Jian-Shiun Chiou, Ming-Kuem Lin, Fuu-Jen Tsai, Yang-Chang Wu, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Yu-Ning Lin, Wen-Miin Liang & Ying-Ju Lin. (2020) Complementary Chinese Herbal Medicine Therapy Improves Survival in Patients With Pemphigus: A Retrospective Study From a Taiwan-Based Registry. Frontiers in Pharmacology 11.
Crossref
Crossref
Ebrahim Mazloom, Maryam Daneshpazhooh, Raheleh Shokouhi Shoormasti, Kamran Balighi, Hamidreza Mahmoudi, Masoud Moradi Ketisari, Vahid Eslami Faresani & Narges Ghandi. (2020) Intralesional injection of biosimilar rituximab in recalcitrant mucocutaneous lesions of patients with pemphigus vulgaris: A pilot study. Dermatologic Therapy 33:6.
Crossref
Crossref
Sonia Chavez-Alvarez, Maira Herz-Ruelas, Alejandra Villarreal-Martinez, Jorge Ocampo-Candiani, Rubicela Garza-Garza & Minerva Gomez-Flores. (2020) Azathioprine: its uses in dermatology. Anais Brasileiros de Dermatologia 95:6, pages 731-736.
Crossref
Crossref
Ya-Gang Zuo, Li Li, Jin-Bo Chen, Liu-Qing Chen, Su-Ying Feng, Wei Li, Xiao-Qun Luo, Meng Pan, Gang Wang, Ting Xiao, Bao-Qi Yang, Kang Zeng, Gui-Ying Zhang & Hong-Zhong Jin. (2020) Chinese Expert Proposal on the Diagnosis and Management of Pemphigus Vulgaris (2020)#. International Journal of Dermatology and Venereology 3:3, pages 148-155.
Crossref
Crossref
Omeed Memar, Sayena Jabbehdari, Benjamin Caughlin & Ali R. Djalilian. (2020) Ocular surface involvement in pemphigus vulgaris: An interdisciplinary review. The Ocular Surface 18:1, pages 40-46.
Crossref
Crossref
Reshmi Gangan. (2019) Refractory pemphigus vulgaris: Treatment options. Journal of Skin and Sexually Transmitted Diseases 1, pages 61-65.
Crossref
Crossref
Michael McFarlane, Ayesha Azam, David Snead & Ben Disney. (2018) Oesophageal pemphigoid: a rare cause of dysphagia. Clinical Journal of Gastroenterology 12:1, pages 25-28.
Crossref
Crossref
Camilla Loi, Michela Magnano, Giulia Maria Ravaioli, Lidia Sacchelli, Annalisa Patrizi & Federico Bardazzi. (2019) Rituximab therapy in pemphigus: A long-term follow-up. Dermatologic Therapy 32:1, pages e12763.
Crossref
Crossref
Esther Q. Wang & Dedee F. Murrell. 2019. Cutaneous Biometrics. Cutaneous Biometrics
1
24
.
Kalani S Hettiarachchi, Ruwan D Jayasinghe, Chandira Gunasena & Primali Jayasooriya. (2018) Juvenile Pemphigus Vulgaris as a Differential Diagnosis for Chronic Generalized Oral Ulceration in an Adolescent: A Case Report and a Review of Literature. International Journal of Experimental Dental Science 7:2, pages 143-143.
Crossref
Crossref
Istvan A. Hargitai. (2018) Painful Oral Lesions. Dental Clinics of North America 62:4, pages 597-609.
Crossref
Crossref
Emily Nadelmann & Annette Czernik. 2018. Autoimmune Bullous Diseases. Autoimmune Bullous Diseases.
Hiram de Almeida LarangeiraJr.Jr.. 2018. Dermatology in Public Health Environments. Dermatology in Public Health Environments
507
512
.
Soheil Tavakolpour. (2017) Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?. International Immunopharmacology 53, pages 133-142.
Crossref
Crossref
Robert A. Norman, Martin Walsh & Morgan Naylor. (2016) Overview and Update in Geriatric Dermatology. Current Geriatrics Reports 5:4, pages 275-282.
Crossref
Crossref
A. Razzaque Ahmed, Tegan Nguyen, Srini Kaveri & Zachary S. Spigelman. (2016) First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up. International Immunopharmacology 34, pages 25-31.
Crossref
Crossref